Patents by Inventor Monica Tejwani
Monica Tejwani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230087923Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: ApplicationFiled: August 23, 2022Publication date: March 23, 2023Applicant: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.Inventors: Mark D. Soll, Joseph K. Rosentel, James Pate, Natalya Shub, Monica Tejwani-Motwani, Carol Belansky
-
Patent number: 11464763Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: GrantFiled: September 3, 2020Date of Patent: October 11, 2022Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.Inventors: Mark D. Soll, Joseph K. Rosentel, Jr., James Pate, Natalya Shub, Monica Tejwani-Motwani, Carol Belansky
-
Publication number: 20210128533Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: ApplicationFiled: September 3, 2020Publication date: May 6, 2021Applicant: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.Inventors: Mark D. Soll, Joseph K. Rosentel, JR., James Pate, Natalya Shub, Monica Tejwani-Motwani, Carol Belansky
-
Patent number: 10786487Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: GrantFiled: January 14, 2019Date of Patent: September 29, 2020Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.Inventors: Mark D. Soll, Joseph K. Rosentel, Jr., James Pate, Natalya Shub, Monica Tejwani-Motwani, Carol Belansky
-
Patent number: 10383854Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: GrantFiled: October 5, 2016Date of Patent: August 20, 2019Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.Inventors: Mark D. Soll, Joseph K. Rosentel, Jr., Monica Tejwani-Motwani, Carol Belansky
-
Publication number: 20190216784Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: ApplicationFiled: January 14, 2019Publication date: July 18, 2019Applicant: MERIAL, INC.Inventors: Mark D. Soll, Joseph K. Rosentel, JR., James Pate, Natalya Shub, Monica Tejwani-Motwani, Carol Belansky
-
Patent number: 9877950Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: GrantFiled: November 3, 2015Date of Patent: January 30, 2018Assignee: MERIAL INC.Inventors: Mark D. Soll, Joseph K. Rosentel, Monica Tejwani-Motwani, Carol Belansky
-
Patent number: 9770449Abstract: This invention relates to compositions for combating ectoparasites and endoparasites in animals, comprising at least one 1-arylpyrazole, at least one macrocyclic lactone, at least one insect growth regulator, and at least one anthelmintic compound in combination with a pharmaceutically acceptable carrier. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: GrantFiled: September 29, 2015Date of Patent: September 26, 2017Assignee: MERIAL INC.Inventors: Joseph K. Rosentel, Jr., Monica Tejwani, Arima Das-Nandy
-
Publication number: 20170020849Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: ApplicationFiled: October 5, 2016Publication date: January 26, 2017Applicant: MERIAL, INC.Inventors: Mark D. Soll, Joseph K. Rosentel, JR., Monica Tejwani-Motwani, Carol Belansky
-
Publication number: 20160220566Abstract: This invention relates to compositions for combating ectoparasites and endoparasites in animals, comprising at least one 1-arylpyrazole, at least one macrocyclic lactone, at least one insect growth regulator, and at least one anthelmintic compound in combination with a pharmaceutically acceptable carrier. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: ApplicationFiled: September 29, 2015Publication date: August 4, 2016Applicant: MERIAL, INC.Inventors: Joseph K. Rosentel, JR., Monica Tejwani, Arima Das-Nandy
-
Publication number: 20160051519Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: ApplicationFiled: November 3, 2015Publication date: February 25, 2016Applicant: MERIAL, INC.Inventors: Mark D. Soll, Joseph K. Rosentel, JR., James Pate, Natalya Shub, Monica Tejwani-Motwani, Carol Belansky
-
Patent number: 9173403Abstract: This invention relates to compositions for combating ectoparasites and endoparasites in animals, comprising at least one 1-arylpyrazole, at least one macrocyclic lactone, at least one insect growth regulator, and at least one anthelmintic compound in combination with a pharmaceutically acceptable carrier. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: GrantFiled: April 1, 2011Date of Patent: November 3, 2015Assignee: MERIAL, INC.Inventors: Joseph K. Rosentel, Jr., Monica Tejwani, Arima Das-Nandy
-
Patent number: 8465777Abstract: The invention includes a core-and-shell dosage form or unit in which the core contains API and in which the shell substantially governs the release such as by controlling diffusion of API through the shell. The shell may comprise a release-blocking polymer, and particles of a release-regulating polymer. The shell may be substantially impervious but the release-regulating polymer may become suitable to allow diffusion through it when activated. The core may include a buffer region between the shell and the API-containing portion of the core. The dosage form may include multiple units. The dosage form of the invention is capable of providing a release profile whose time scale can be adjusted by adjusting powder composition, and which may be approximately zero-order release. The invention further includes methods of manufacturing such a dosage form, such as three-dimensional printing.Type: GrantFiled: November 29, 2011Date of Patent: June 18, 2013Assignee: The Massachusetts Institute of TechnologyInventors: Chen-Chao Wang, Jaedeok Yoo, Esteban Bornancini, Willie J Roach, Monica Tejwani
-
Patent number: 8362086Abstract: The application relates to long acting injectable (LAI) formulations for combating ectoparasites and endoparasites in mammals. In particular, this invention provides for a LAI formulation comprising a subcutaneously volatile solvent, a biologically acceptable polymer, a bioactive agents and optionally one or more anti-ectoparasitically or anti-endoparasitically acceptable additive or excipient. Surprisingly, the liquid long acting injectable formulations of the invention solve the problems associates with previous injectable formulations by having long term stability, being able to accommodate smaller needle diameters and achieving long acting effects in the control of pests in a mammal. The unique formulations of the invention also allow for combating ectoparasites and endoparasites which have become resistant to macrolide antibiotics.Type: GrantFiled: August 19, 2005Date of Patent: January 29, 2013Assignee: Merial LimitedInventors: Mark D. Soll, Peter Hanson, Krishan Kumar, Monica Tejwani-Motwani
-
Publication number: 20120177696Abstract: The invention includes a core-and-shell dosage form or unit in which the core contains API and in which the shell substantially governs the release such as by controlling diffusion of API through the shell. The shell may comprise a release-blocking polymer, and particles of a release-regulating polymer. The shell may be substantially impervious but the release-regulating polymer may become suitable to allow diffusion through it when activated. The core may include a buffer region between the shell and the API-containing portion of the core. The dosage form may include multiple units. The dosage form of the invention is capable of providing a release profile whose time scale can be adjusted by adjusting powder composition, and which may be approximately zero-order release. The invention further includes methods of manufacturing such a dosage form, such as three-dimensional printing.Type: ApplicationFiled: November 29, 2011Publication date: July 12, 2012Applicant: THE MASSACHUSETTS INSTITUTE OF TECHNOLOGYInventors: Chen-Chao WANG, Jaedeok YOO, Esteban BORNANCINI, Willie J. ROACH, Monica TEJWANI
-
Publication number: 20110245191Abstract: This invention relates to compositions for combating ectoparasites and endoparasites in animals, comprising at least one 1-arylpyrazole, at least one macrocyclic lactone, at least one insect growth regulator, and at least one anthelmintic compound in combination with a pharmaceutically acceptable carrier. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: ApplicationFiled: April 1, 2011Publication date: October 6, 2011Inventors: Joseph K Rosentel, JR., Monica Tejwani, Arima Das-Nandy
-
Publication number: 20080160067Abstract: This document relates to formulations for combating bacterial infections in animals which provide for improved long-acting oral and injectable formulations for systemic delivery of antibiotics, which are designed to achieve high bioavailability.Type: ApplicationFiled: September 5, 2007Publication date: July 3, 2008Inventors: Albert Boeckh, Mark D. Soll, Monica Tejwani-Motwani, Robert P. Waranis, Fangjun Wu
-
Publication number: 20070042013Abstract: The application relates to long acting injectable (LAI) formulations for combating ectoparasites and endoparasites in mammals. In particular, this invention provides for a LAI formulation comprising a subcutaneously volatile solvent, a biologically acceptable polymer, a bioactive agents and optionally one or more anti-ectoparasitically or anti-endoparasitically acceptable additive or excipient. Surprisingly, the liquid long acting injectable formulations of the invention solve the problems associates with previous injectable formulations by having long term stability, being able to accommodate smaller needle diameters and achieving long acting effects in the control of pests in a mammal. The unique formulations of the invention also allow for combating ectoparasites and endoparasites which have become resistant to macrolide antibiotics.Type: ApplicationFiled: August 19, 2005Publication date: February 22, 2007Inventors: Mark Soll, Peter Hanson, Krishan Kumar, Monica Tejwani-Motwani